Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-17T19:37:32.034Z Has data issue: false hasContentIssue false
  • English
  • Français

Characteristics and prognostic factors for head and neck non-Hodgkin's lymphoma in Chinese patients

Published online by Cambridge University Press:  06 June 2013

J Wang ,
C-P Cai ,
S-F He  and
S-L Wang
J Wang
Affiliation:
Department of Otolaryngology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, China
C-P Cai
Affiliation:
Department of Otolaryngology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, China
S-F He
Affiliation:
Department of Otolaryngology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, China
S-L Wang*
Affiliation:
Department of Otolaryngology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, China
*
Address for correspondence: Mr Shili Wang, Department of Otolaryngology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China Fax: +86 2164333548 E-mail: shiliwang88@hotmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Background and objectives:

The head and neck region is the second most frequent anatomical site of extranodal lymphomas. These tumours affect many individuals worldwide, justifying epidemiological studies in different countries. This study evaluated the characteristics, treatments and prognostic factors for non-Hodgkin's lymphoma of the head and neck in Chinese patients.

Method:

The clinical manifestations, clinicopathological characteristics, multidisciplinary treatment and prognostic factors for 102 patients with extranodal non-Hodgkin's lymphoma of the head and neck were analysed retrospectively.

Result:

The tonsil was the most commonly involved primary site, followed by the nasal cavity. The most common histological subtype was diffuse large B-cell lymphoma, followed by natural killer T-cell lymphoma. Patients receiving a combination of rituximab and chemotherapy did better than those receiving chemotherapy alone. Prognosis was significantly associated with both International Prognostic Index and histological subtype; the former was especially strongly associated with poor survival.

Conclusion:

In this group of Chinese patients, diffuse large B-cell lymphoma was the most common pathological subtype, but the incidence of T-cell lymphomas was higher than that reported in the USA. Combined rituximab and chemotherapy led to better outcomes than chemotherapy alone. Prognosis depended on both International Prognostic Index and histological subtype.

Keywords

Head And Neck NeoplasmsLymphomaNon-HodgkinTreatment
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 127 , Issue 7 , July 2013 , pp. 699 - 704
Copyright
Copyright © JLO (1984) Limited 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Boring, CC, Squires, TS, Tong, T.Cancer statistics. CA Cancer J Clin 1993;43:7–26CrossRefGoogle ScholarPubMed
2Kolokotronis, A, Konstantinou, N, Christakis, I, Papadimitriou, P, Matiakis, A, Zaraboukas, T et al. Localized B-cell non-Hodgkin's lymphoma of oral cavity and maxillofacial region: a clinical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;99:303–10CrossRefGoogle ScholarPubMed
3Hanna, E, Wanamaker, J, Adelstein, D, Tubbs, R, Lavertu, P.Extranodal lymphomas of the head and neck. A 20-year experience. Arch Otolaryngol Head Neck Surg 1997;123:1318–23CrossRefGoogle Scholar
4King, AD, Lei, KI, Richards, PS, Ahuja, AT.Non-Hodgkin's lymphoma of the nasopharynx: CT and MR imaging. Clin Radiol 2003;58:621–5CrossRefGoogle ScholarPubMed
5Urquhart, A, Berg, R.Hodgkin's and non-Hodgkin's lymphoma of the head and neck. Laryngoscope 2001;111:1565–9CrossRefGoogle ScholarPubMed
6Weisenburger, DD.Epidemiology of non-Hodgkin's lymphoma: recent findings regarding an emerging epidemic. Ann Oncol 1994;5:19–24CrossRefGoogle ScholarPubMed
7Vega, F, Lin, P, Medeiros, J.Extranodal lymphomas of the head and neck. Ann Diagn Pathol 2005;9:340–50CrossRefGoogle ScholarPubMed
8Jacobs, C, Hoppe, RT.Non-Hodgkin's lymphomas of head and neck extranodal sites. Int J Radiat Oncol Biol Phys 1985;11:357–64CrossRefGoogle ScholarPubMed
9Ekstrom-Smedby, K.Epidemiology and etiology of non-Hodgkin lymphoma – a review. Acta Oncol 2006;45:258–71CrossRefGoogle ScholarPubMed
10Economopoulos, T, Asprou, N, Stathakis, N, Fountzilas, G, Pavlidis, N, Papaspyrou, S et al. Primary extranodal non-Hodgkin's lymphoma of the head and neck. Oncology 1992;49:484–8CrossRefGoogle ScholarPubMed
11Moormeier, JA, Williams, SF, Golomb, HM.The staging of non Hodgkin's lymphomas. Semin Oncol 1990;17:43–50Google ScholarPubMed
12Etemad-Moghadam, S, Tirgary, F, Keshavarz, S, Alaeddini, M.Head and neck non-Hodgkin's lymphoma: a 20-year demographic study of 381 cases. Int J Oral Maxillofac Surg 2010;39:869–72CrossRefGoogle ScholarPubMed
13Anderson, JR, Armitage, JO, Weisenburger, DD.Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Ann Oncol 1998;9:717–20CrossRefGoogle ScholarPubMed
14Oluwasanmi, AF, Wood, SJ, Baldwin, DL, Sipaul, F.Malignancy in asymmetrical but otherwise normal palatine tonsils. Ear Nose Throat J 2006;85:661–3CrossRefGoogle ScholarPubMed
15Blinder, V, Fisher, SG.The role of environmental factors in the etiology of lymphoma. Cancer Invest 2008;26:306–16CrossRefGoogle ScholarPubMed
16Friedberg, JW, Fisher, RI.Diffuse large B-cell lymphoma. Hematol Oncol Clin North Am 2008;22:941–52CrossRefGoogle ScholarPubMed
17Shipp, MA, Ross, KN, Tamayo, P, Weng, AP, Kutok, JL, Aguiar, RC et al. Diffuse large B-cell lymphoma outcome prediction by gene expression profiling and supervised machine learning. Nat Med 2002;8:68–74CrossRefGoogle ScholarPubMed
18Robertson, MJ, Kahl, BS, Vose, JM, de Vos, S, Laughlin, M, Flynn, PJ et al. Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma. J Clin Oncol 2007;25:1741–6CrossRefGoogle ScholarPubMed
19Wiernik, PH, Lossos, IS, Tuscano, JM, Justice, G, Vose, JM, Cole, CE et al. Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma. J Clin Oncol 2008;26:4952–7CrossRefGoogle ScholarPubMed
20Harabuchi, Y, Imai, S, Wakashima, J, Hirao, M, Kataura, A, Osato, T et al. Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies. Cancer 1996;77:2137–493.0.CO;2-V>CrossRefGoogle ScholarPubMed
21Harabuchi, Y, Yamanaka, N, Kataura, A, Imai, S, Kinoshita, T, Mizuno, F et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990;335:128–30CrossRefGoogle ScholarPubMed
22Aozasa, K, Ohsawa, M, Tajima, K, Sasaki, R, Maeda, H, Matsunaga, T et al. Nation-wide study of lethal mid-line granuloma in Japan: frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions. Int J Cancer 1989;44:63–6CrossRefGoogle ScholarPubMed
23Lee, J, Suh, C, Park, YH, Ko, YH, Bang, SM, Lee, JH et al. Extranodal natural killer T cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006;24:612–18CrossRefGoogle ScholarPubMed
24Jaffe, ES, Chan, JK, Su, IJ, Frizzera, G, Mori, S, Feller, AC et al. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996;20:103–11CrossRefGoogle ScholarPubMed
25Altemani, A, Barbosa, AC, Kulka, M, Takahashi, T, Endo, L, Vassallo, J et al. Characteristics of nasal T/NK-cell lymphoma among Brazilians. Neoplasma 2002;49:55–60Google ScholarPubMed
26Gaal, K, Sun, NC, Hernandez, AM, Arber, DA.Sinonasal NK/T-cell lymphomas in the United States. Am J Surg Pathol 2000;24:1511–17CrossRefGoogle ScholarPubMed
27Yamanaka, N, Harabuchi, Y, Sambe, S, Shido, F, Matsuda, F, Kataura, A et al. Non-Hodgkin's lymphoma of Waldeyer's ring and nasal cavity. Clinical and immunologic aspects. Cancer 1985;56:768–763.0.CO;2-W>CrossRefGoogle ScholarPubMed
28Wu, X, Li, P, Zhao, J, Yang, X, Wang, F, Yang, YQ et al. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type. Clin Oncol (R Coll Radiol) 2008;20:619–25CrossRefGoogle ScholarPubMed
29Takenaka, K, Shinagawa, K, Maeda, Y, Makita, M, Kozuka, T, Ashiba, A et al. High-dose chemotherapy with hematopoietic stem cell transplantation is effective for nasal and nasal-type CD56+ natural killer cell lymphomas. Leuk Lymphoma 2001;42:1297–303CrossRefGoogle ScholarPubMed
30Murashige, N, Kami, M, Kishi, Y, Kim, SW, Takeuchi, M, Matsue, K et al. Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms. Br J Haematol 2005;130:561–7CrossRefGoogle ScholarPubMed
31Suzuki, R, Suzumiya, J, Nakamura, S, Kagami, Y, Kameoka, JI, Sakai, C et al. Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms. Bone Marrow Transplant 2006;37:425–31CrossRefGoogle ScholarPubMed
32Shipp, MA, Harrington, DP, Anderson, JR, Armitage, JO, Bonadonna, G, Brittinger, G.A predictive model for aggressive non-Hodgkin's lymphoma: the International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993;329:987–94Google Scholar
33Vidulich, KA, Talpur, R, Bassett, RL, Duvic, M.Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma. Int J Dermatol 2009;48:243–52CrossRefGoogle Scholar